Streetbeat News

MRMD

MariMed Inc

Employees

326

Industry

Medicinal and Botanical Manufacturing

Open

0.10

Mkt cap

39M

Volume

101K

High

0.10

P/E Ratio

-3.43

52-wk high

0.34

Low

0.10

Div yield

N/A

52-wk low

0.10

Cannabis stocks experienced significant movements on March 25, 2024, with notable gainers including Beleave, Green Growth Brands, and Auxly Cannabis Group, while losers comprised Global Hemp Group, Elixinol Wellness, and SOL Global Investments. Major US-listed companies like GrowGeneration, Canopy Growth, Aurora Cannabis, OrganiGram Holdings, Greenlane Holdings, Tilray Brands, Cara Therapeutics, and Cronos Group also saw varied stock price changes.

Portfolio Pulse from Benzinga Insights

March 25, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on March 22, 2024, with notable gainers including Canopy Growth, Aurora Cannabis, and SNDL, among others. Losers included Belgravia Hartford Cap, Heritage Cannabis Holding, and Elixinol Wellness. The movements reflect the volatile nature of the cannabis market.

Portfolio Pulse from Benzinga Insights

March 22, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on March 19, 2024, with notable gainers including Canopy Growth, Body and Mind, and Charlotte's Web Holdings, among others. Conversely, several companies faced declines, such as Item 9 Labs and Heritage Cannabis Holding. The fluctuations highlight the volatile nature of the cannabis market.

Portfolio Pulse from Benzinga Insights

March 19, 2024 | 9:30 pm

The cannabis industry is experiencing significant growth with new store openings and sales milestones ahead of the Benzinga Cannabis Capital Conference in Florida. Illinois' cannabis market continues to expand, with MariMed Inc. opening a new Thrive dispensary. In Florida, Trulieve Cannabis Corp. and Green Thumb Industries Inc. are expanding their retail footprints amid talks of recreational legalization. AYR Wellness Inc. relocated its Tallahassee dispensary, and in New Jersey, C3 Industries Inc. and Holistic Re-Leaf opened new stores. Pennsylvania sees expansion with new dispensaries by PharmaCann Inc. and Cresco Labs Inc.

Portfolio Pulse from Jelena Martinovic

March 19, 2024 | 2:51 pm

Marijuana stocks experienced significant gains on a bullish Monday, with Greenlane Holdings leading the surge at 31.82% increase. Notable gainers include Heritage Cannabis, Canopy Growth, and Aurora Cannabis among others. Conversely, a few companies like Rocky Mountain High and Global Compliance faced declines.

Portfolio Pulse from Benzinga Insights

March 18, 2024 | 9:30 pm

The 4th quarter 2023 earnings for the cannabis sector showed a positive trend with a significant correlation between EBITDA surprises and stock performance. Green Thumb and Trulieve reported notable EBITDA beats, while Marimed, Cannabist, and TerrAscend faced significant misses. Analysts have adjusted their 2024 EBITDA estimates slightly downwards, reflecting modest expectations for revenue growth and margin expansion. The Viridian Cannabis Deal Tracker highlights the importance of these trends for investors.

Portfolio Pulse from Viridian Capital Advisors

March 18, 2024 | 4:46 pm

Cannabis stocks experienced significant movements on March 15, 2024, with notable gainers including CordovaCann, Global Hemp Group, and Canopy Growth, among others. Conversely, Australis Capital led the losers with a dramatic drop. The movements reflect varying investor sentiments and market dynamics within the cannabis sector.

Portfolio Pulse from Benzinga Insights

March 15, 2024 | 9:30 pm

The article reports on significant price movements in the cannabis stock market on March 14, 2024, listing both gainers and losers. Notable gainers include Australis Capital with a 9900.00% increase, while CordovaCann led the losers with a 37.42% decrease. Other companies experienced various degrees of gains and losses, reflecting the volatile nature of the cannabis market.

Portfolio Pulse from Benzinga Insights

March 14, 2024 | 9:30 pm

MariMed Inc. (OTC:MRMD) reported a 48% increase in wholesale revenue for 2023, with projections of over 20% growth for 2024, despite its CY24 sales guidance being below expectations. The company trades at 4.6x EBITDA, below the MSO average of 7.3x. Analyst Pablo Zuanic maintains an Overweight rating on MRMD, citing strong wholesale growth and underutilized brand power, despite a 21% decrease in MRMD shares over the past 90 days. The MSOS ETF (NYSE:MSOS) has only 1% ownership in MariMed, compared to 10-14% for companies like Jushi (OTC: JUSHF) and AYR (OTC:AYRWF), contributing to MariMed's underperformance. Zuanic sees limited downside risk and potential for future gains, especially with strategic expansions.

Portfolio Pulse from Nicolás Jose Rodriguez

March 13, 2024 | 8:25 pm

On March 12, 2024, several cannabis stocks experienced significant price movements. Notable gainers included MedMen Enterprises, AusCann Group Holdings, and Target Group, with increases of 900%, 816.67%, and 40.74% respectively. On the downside, 1933 Industries led the losers, dropping 30.77%, followed by Heritage Cannabis Holding and Rocky Mountain High with declines of 20% and 19.35%. Corbus Pharmaceuticals and Village Farms Intl were among the few NASDAQ-listed companies mentioned, with gains of 6.06% and 4.25%.

Portfolio Pulse from Benzinga Insights

March 12, 2024 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.